bioMérieux: launches 3 Covid-19 diagnostic tests
(CercleFinance.com) - bioMérieux announces the upcoming launch of 3 tests aimed at responding to the Covid-19 epidemic.
These tests will meet the different needs of clinicians and health authorities in the fight against this new infectious disease.
bioMérieux has finalised the development of the SARS-COV-2 R-GENE test. "This real-time PCR test is clinically validated on one type of respiratory specimen and will be available at the end of March," the group says.
It is expected to be rapidly CE marked and submitted to the FDA for an EUA (Emergency Use Authorization) as well.
"In the face of the urgency of the COVID-19 epidemic, bioMérieux is committed to provide a comprehensive diagnostic approach that meets the highest performance and quality standards to help physicians mount an effective response to the outbreak," said Dr. Mark Miller, Executive Vice President and Chief Medical Officer of bioMérieux.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
These tests will meet the different needs of clinicians and health authorities in the fight against this new infectious disease.
bioMérieux has finalised the development of the SARS-COV-2 R-GENE test. "This real-time PCR test is clinically validated on one type of respiratory specimen and will be available at the end of March," the group says.
It is expected to be rapidly CE marked and submitted to the FDA for an EUA (Emergency Use Authorization) as well.
"In the face of the urgency of the COVID-19 epidemic, bioMérieux is committed to provide a comprehensive diagnostic approach that meets the highest performance and quality standards to help physicians mount an effective response to the outbreak," said Dr. Mark Miller, Executive Vice President and Chief Medical Officer of bioMérieux.
Copyright (c) 2020 CercleFinance.com. All rights reserved.